Gsk GSK
NYSE GSK
$51.96 -0.95 (-1.80%)
At close: Aug 20, 2026 · 4:00 PM EDT

Gsk (GSK) EBT (2009 - 2026)

Gsk (GSK) posted quarterly EBT of $475.0 million for Q2 2026, down 81.13% year-over-year from $2.5 billion in Q2 2025, and down 83.57% quarter-over-quarter from $2.9 billion in Q1 2026.

Gsk (GSK) EBT (2009 - 2026) Analysis & Trends

Gsk's EBT history runs 18 years deep, the most recent figure standing at $475.0 million for Q2 2026.

  • In Q2 2026, EBT fell 81.13% year-over-year to $475.0 million; the TTM figure through Jun 2026 stood at $12.0 billion (up 34.55% YoY), while the FY2025 annual figure was $9.8 billion, up 119.56% from the prior year.
  • EBT for Q2 2026 stood at $475.0 million, down from $2.9 billion in the prior quarter.
  • The five-year high for EBT was $5.3 billion in Q4 2025, with the low at $83.2 million in Q3 2024.
  • The 5-year median for EBT is $2.5 billion (2023), against an average of $2.5 billion.
  • The sharpest annual moves came in 2024 and 2025: EBT sank 96.33% in 2024, then surged 3885.36% in 2025.
  • Gsk's EBT stood at $3.5 billion in 2022, then jumped by 37.81% to $4.8 billion in 2023, then fell by 24.31% to $3.7 billion in 2024, then surged by 45.27% to $5.3 billion in 2025, then plunged by 91.06% to $475.0 million in 2026.
  • Business Quant data shows GSK's EBT at $475.0 million in Q2 2026, $2.9 billion in Q1 2026, and $5.3 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 6.75 Bn
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 4.28 Bn
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn -683.00 Mn
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 4.27 Bn
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 2.80 Bn
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 2.77 Bn
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -10.25 Bn
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -653.00 Mn
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 474.95 Mn
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 17.19 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 474.95 Mn
Mar 31, 2026 2.89 Bn
Dec 31, 2025 5.31 Bn
Sep 30, 2025 3.31 Bn
Jun 30, 2025 2.52 Bn
Mar 31, 2025 2.66 Bn
Dec 31, 2024 3.66 Bn
Sep 30, 2024 83.16 Mn
Jun 30, 2024 1.89 Bn
Mar 31, 2024 1.72 Bn
Dec 31, 2023 4.83 Bn
Sep 30, 2023 2.27 Bn
Jun 30, 2023 2.49 Bn
Mar 31, 2023 2.32 Bn
Dec 31, 2022 3.51 Bn
Sep 30, 2022 1.19 Bn
Jun 30, 2022 1.13 Bn
Mar 31, 2022 2.81 Bn
Dec 31, 2021 2.84 Bn
Sep 30, 2021 1.64 Bn